Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
about
Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Antibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationThe Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update.Follicular T helper cells and humoral reactivity in kidney transplant patients.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss.Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
P2860
Q27314948-6E20D4CB-4119-4716-B1D5-0ADF4B95801EQ28076193-EA350627-AA97-4A55-AB86-063A4D2045C0Q30397251-E6361F45-8148-4ECD-AF1B-F84D1B422530Q36417907-2E857516-01DC-4BBF-BEF6-EF393909B472Q37527388-88CABE5B-7251-4BE1-BBDF-805AE9F59762Q37611251-7B4AD748-70DA-406F-86DF-08AE52EC1651Q38341785-2B26A12C-DF1E-45B8-BEC2-B24C5A6CE75BQ38923388-97A413CD-1EDE-4BE6-ABBF-5429C655B693Q39217968-8E10B43F-A85F-4E72-9ADA-CB7CE75CA784Q39366396-3C3D1CA7-A3EA-4607-AB3F-B76B9C6730F1Q51585363-3A72AB77-C2BB-481D-B951-CB1B7348D6B1Q54969814-6004749F-6634-44F8-9D96-F1F2303A1540Q58718244-986BDB73-6433-4392-89CE-F58B215C84F8
P2860
Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@en
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@nl
type
label
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@en
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@nl
prefLabel
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@en
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@nl
P2093
P2860
P356
P1476
Donor-specific HLA antibodies: ...... /IgG4 anti-HLA alloantibodies.
@en
P2093
Aliki G Iniotaki
Bernd M Spriewald
Ilias I N Doxiadis
Irma-Sofia Ntokou
John N Boletis
Marie-Luise Arnold
P2860
P304
P356
10.1111/TRI.12206
P577
2013-10-31T00:00:00Z